PartnershipsWe are actively pursuing collaborative partnership opportunities in the area of targeted in vivo delivery and other approaches to off-the-shelf dendritic cell vaccines. We will consider partnership opportunities leading to clinical applications of CID technology in other signaling pathways and diseases, or broader clinical deployment of our CaspaCIDe™ technology, on a case by case basis. Interested parties please contact:
Tom Farrell |
